The U.S. government will pay as much as $1.5 billion to buy 100 million doses of Moderna's experimental coronavirus vaccine, securing supplies of a shot that it's helped to develop and advance quickly into late-stage clinical trials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,